Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensitivity to Intravenous Nicotine: Genetic Moderators

NCT00969137 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00969137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00969137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensitivity to Intravenous Nicotine: Genetic Moderators
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
June 2, 2009
Completion date
June 1, 2016
Enrollment
213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence